The Peptide Report
A definitive 2026 regulatory guide to SLU-PP-332 — covering its FDA status, research compound classification, and what buyers should know before purchasing. Learn how to identify legitimate providers and avoid unregulated sources.
SLU-PP-332 sits in a unique regulatory category in 2026 — not an approved drug, not a dietary supplement, but a research compound with specific legal nuances. Here's what consumers need to understand before purchasing.
SLU-PP-332 sits in a regulatory gray zone in 2026 — not FDA-approved, typically sold for research use, and surrounded by buyer confusion. Here's the clear-eyed legal breakdown.
